STOCK TITAN

Gelteq Appoints Matthew Jones as Head of Sports Performance

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

Gelteq (NASDAQ: GELS) has appointed Matthew Jones as Head of Sports Performance to oversee the growth, outreach, and customer strategy of its sports vertical. Jones, an internationally-experienced sports dietitian, currently serves as Head of Nutrition with the UAE Football Association and consults for the Boston Celtics.

Jones brings over 12 years of elite sports experience, including work in international football, English Premier League, Women's Super League, and NCAA Division I sports. He holds a Master's Degree in Nutrition Science from University of Chester and is registered with the British Dietetic Association, Sport Nutrition Register.

The appointment aligns with Gelteq's strategy to expand its ingestible gel technology in sports nutrition, leveraging its unique formulation for improved nutrient delivery compared to traditional methods.

Gelteq (NASDAQ: GELS) ha nominato Matthew Jones come Responsabile delle Prestazioni Sportive per sovrintendere alla crescita, all'espansione e alla strategia aziendale del suo settore sportivo. Jones, un dietista sportivo con esperienza internazionale, attualmente ricopre il ruolo di Responsabile della Nutrizione presso la Federazione calcistica degli Emirati Arabi Uniti e collabora con i Boston Celtics.

Jones porta con sé oltre 12 anni di esperienza nell'ambito sportivo d'élite, inclusi ruoli nel calcio internazionale, nella Premier League inglese, nella Women's Super League e nello sport NCAA Division I. Ha conseguito un Master in Scienza della Nutrizione presso l'Università di Chester ed è registrato con la British Dietetic Association, Sport Nutrition Register.

La nomina è in linea con la strategia di Gelteq di espandere la sua tecnologia di gel ingeribile nella nutrizione sportiva, sfruttando la sua formulazione unica per un miglioramento nella consegna dei nutrienti rispetto ai metodi tradizionali.

Gelteq (NASDAQ: GELS) ha nombrado a Matthew Jones como Jefe de Rendimiento Deportivo para supervisar el crecimiento, la expansión y la estrategia comercial de su sector deportivo. Jones, un dietista deportivo con experiencia internacional, actualmente se desempeña como Jefe de Nutrición en la Asociación de Fútbol de los EAU y asesora a los Boston Celtics.

Jones aporta más de 12 años de experiencia en deportes de élite, incluidos trabajos en fútbol internacional, la Premier League inglesa, la Women's Super League y deportes de la División I de la NCAA. Tiene una Maestría en Ciencias de la Nutrición de la Universidad de Chester y está registrado en la Asociación Británica de Dietética, Registro de Nutrición Deportiva.

La designación se alinea con la estrategia de Gelteq para expandir su tecnología de gel ingerible en nutrición deportiva, aprovechando su formulación única para mejorar la entrega de nutrientes en comparación con los métodos tradicionales.

겔텍(Gelteq) (NASDAQ: GELS)매튜 존스(Matthew Jones)를 스포츠 성능 책임자로 임명하여 스포츠 부문의 성장, 확장 및 고객 전략을 감독하도록 했습니다. 존스는 국제적으로 경험이 풍부한 스포츠 영양사로 현재 UAE 축구 협회의 영양 책임자를 맡고 있으며 보스턴 셀틱스의 자문을 맡고 있습니다.

존스는 국제 축구, 잉글리시 프리미어 리그, 여성 수퍼 리그 및 NCAA 1부 리그 스포츠에서의 경력을 포함해 12년 이상의 엘리트 스포츠 경험을 가지고 있습니다. 그는 체스터 대학교에서 영양 과학 석사 학위를 취득하였으며, 영국 영양사 협회와 스포츠 영양 등록에 등록되어 있습니다.

이번 임명은 겔텍의 스포츠 영양 분야에서 섭취 가능한 젤 기술을 확장하려는 전략과 일치하며, 전통적인 방법에 비해 개선된 영양소 전달을 위한 독특한 제형을 활용합니다.

Gelteq (NASDAQ: GELS) a nommé Matthew Jones en tant que Responsable des Performances Sportives pour superviser la croissance, l'expansion et la stratégie client de son secteur sportif. Jones, un diététicien sportif avec une expérience internationale, occupe actuellement le poste de Responsable Nutrition à l'Association de Football des Émirats Arabes Unis et est consultant pour les Boston Celtics.

Jones apporte plus de 12 ans d'expérience dans le sport de haut niveau, y compris dans le football international, la Premier League anglaise, la Women's Super League et les sports de la Division I de la NCAA. Il détient un Master en Sciences de la Nutrition de l'Université de Chester et est enregistré auprès de la British Dietetic Association, Sport Nutrition Register.

La nomination est en accord avec la stratégie de Gelteq d'élargir sa technologie de gel ingérable dans la nutrition sportive, exploitant sa formulation unique pour une meilleure livraison des nutriments par rapport aux méthodes traditionnelles.

Gelteq (NASDAQ: GELS) hat Matthew Jones zum Leiter der Sportleistung ernannt, um das Wachstum, die Expansion und die Kundenstrategie seiner Sportabteilung zu überwachen. Jones, ein international erfahrener Sporternährungsberater, ist derzeit als Leiter der Ernährung bei der Fußball-Vereinigung der VAE tätig und berät die Boston Celtics.

Jones bringt über 12 Jahre Erfahrung im Profisport mit, darunter Arbeiten im internationalen Fußball, der englischen Premier League, der Women's Super League und NCAA Division I-Sport. Er hat einen Masterabschluss in Ernährungswissenschaft von der University of Chester und ist in der British Dietetic Association, Sport Nutrition Register, registriert.

Die Ernennung steht im Einklang mit Gelteqs Strategie, seine einnehmbaren Geltechnologien in der Sporternährung auszubauen und seine einzigartige Formulierung für eine verbesserte Nährstoffaufnahme im Vergleich zu traditionellen Methoden zu nutzen.

Positive
  • Strategic expansion into sports nutrition market with experienced leadership hire
  • Appointment brings high-profile sports industry connections (UAE Football, Boston Celtics)
  • Enhanced credibility in sports nutrition sector through hiring of qualified professional
Negative
  • None.

Leading internationally-experienced sports nutritionist joins the Company’s growing team to expand its sports vertical

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Matthew Jones as Head of Sports Performance. He will oversee the growth, outreach, and customer strategy of Gelteq’s sports vertical.

“The sports industry is one of a number of key areas that Gelteq’s unique formulation can pose a significant improvement to nutrient delivery over traditional methods,” said Nathan Givoni, Co-Founder and CEO of Gelteq. “Matthew’s pedigree aligns perfectly for this position with his global experience in high-level sports training and sports dietetics and we are excited to grow the adoption of our gel-based delivery platform in the sports vertical under his guidance.”

“I look forward to beginning this journey toward greater adoption of the gel-based platform for better nutrient and supplement absorption with a focus on sports clientele,” Jones said. “I greatly enjoy simplifying complex nutrition science, and with Gelteq’s unique platform, we have the opportunity to expand on important nutrition science while providing a solution to help athletes improve their nutrition with a better delivery system.”

Mr. Jones is a leading internationally-experienced sports dietitian who currently works as Head of Nutrition with the United Arab Emirates Football Association and as a consultant to the Boston Celtics in the National Basketball Association. He has more than 12 years of applied experience in elite sports, having worked in international football, the English Premier League, the Women’s Super League, and NCAA Division I sports. Jones holds a Master’s Degree in Nutrition Science from University of Chester and is registered with the British Dietetic Association, Sport Nutrition Register.

About Gelteq Limited:
Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a global biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. Gelteq advances and commercializes its delivery solutions within five core verticals: pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications, and sports nutrition. The Company’s unique formulation directly addresses the issues associated with traditional drug delivery methods such as difficulty swallowing, taste of unpalatable ingredients, and dosage control. For more information, visit www.gelteq.com.

Forward-Looking Statements 
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” "will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Gelteq’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the timing and fulfilment of current and future orders relating to Gelteq’s products, the success of new programs, the ability to implement a new strategic plan and the success of a new strategic plan. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gelteq in general, see the risk factors in the Annual Report on 20-F filed on November 15, 2024. All such forward-looking statements speak only as of the date they are made, and Gelteq undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.

Contact:
CORE IR
516-222-2560
PR@gelteq.com


FAQ

What role did Matthew Jones take at Gelteq (GELS) in January 2024?

Matthew Jones was appointed as Head of Sports Performance at Gelteq (GELS), responsible for overseeing the growth, outreach, and customer strategy of the company's sports vertical.

What is Matthew Jones's professional background before joining Gelteq (GELS)?

Jones is Head of Nutrition with the UAE Football Association, consults for the Boston Celtics, and has over 12 years of experience in elite sports, including work in international football, English Premier League, Women's Super League, and NCAA Division I sports.

How does Gelteq's (GELS) technology benefit sports nutrition?

Gelteq's unique gel-based delivery platform offers improved nutrient delivery and better supplement absorption compared to traditional methods, potentially benefiting athletic performance.

What are Matthew Jones's qualifications for his role at Gelteq (GELS)?

Jones holds a Master's Degree in Nutrition Science from University of Chester and is registered with the British Dietetic Association, Sport Nutrition Register.

Gelteq Limited

NASDAQ:GELS

GELS Rankings

GELS Latest News

GELS Stock Data

17.18M
1.30M
65.03%
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Australia
Caulfield